Deciduous Therapeutics logo

Deciduous Therapeutics

San Francisco, CA

Deciduous is developing a novel class of immune-modulatory therapies designed to promote a healthy lifespan.

deciduoustx.com

Company Details

Founded

2018

Employees

Between 20 - 50 employees

Raised

$16,500,000

Headquarters Location

San Francisco, CA

Public

No

Acquired

No

CEO

Robin MansukhaniRobin Mansukhani

Founders

Robin Mansukhani
Robin Mansukhani
Anil Bhushan
Anil Bhushan

Company Collections

These are collections Deciduous Therapeutics is a part of. Click on the collection name to view similar companies.

Deciduous Therapeutics' Tech Stack

Deciduous Therapeutics' Investors

Company Collections For Deciduous Therapeutics

Deciduous Therapeutics Headquarters Location

953 Indiana Street, San Francisco, CA 94107

Total Amount Raised: $16,500,000

Deciduous Therapeutics' Investors

Deciduous Therapeutics Funding Rounds

  • Seed

    $10,000,000

    Seed Investors

    Bold Capital Partners
    Humboldt Fund
    Owl Capital
    Healthspan Capital
  • Seed

    $6,500,000

    Seed Investors

    CRV
    8VC
    Presight Capital
    The Longevity Fund
Funding info provided by Diffbot.

Deciduous Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Deciduous Therapeutics.

Recent reviews